Canadian researchers have developed a 10-minute tool that they claim can “rapidly, easily, and validly” assess global neurocognition in people with schizophrenia.
Furthermore, scores on the Brief Neurocognitive Assessment (BNA) tool were associated with important clinical outcomes such as symptoms and functional status, with comparable accuracy to that of a full cognitive battery.
“This tool provides clinicians and researchers a means to assess global neurocognitive impairments without requiring extensive neuropsychological testing,” write Gagan Fervaha (Centre for Addiction and Mental Health, Toronto, Ontario) and fellow researchers in the Journal of Psychiatric Research.